Business Context and Reporting Period
This Form 6-K filing is submitted by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in request metadata) for the month of June 2016. The registrant is a foreign private issuer based in the United Kingdom. The filing serves to incorporate by reference a press release dated June 30, 2016, announcing the posting of the company's Annual Report.
Key Financial Metrics
The provided filing text is a cover sheet and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes versus the prior comparable period are detailed in this specific filing text. The document solely references the availability of the Annual Report via a press release.
Guidance, Outlook, and Risks
The filing text contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are expected to be contained within the referenced Annual Report (Exhibit 99.1), which is not included in the input text.
Investor Verification Checklist
- Verify the discrepancy between the request metadata ("Biodexa Pharmaceuticals Plc") and the filing registrant name ("Midatech Pharma PLC").
- Access the referenced Annual Report (Exhibit 99.1) to obtain actual financial figures and operational updates.
- Confirm the filing date of June 30, 2016, aligns with the company's fiscal year-end reporting schedule.